Regulation of E-cadherin and Β-catenin by Ca 2+  in colon carcinoma is dependent on calcium-sensing receptor expression and function by Bhagavathula, Narasimharao et al.
Regulation of E-cadherin and b-catenin by Ca21 in colon carcinoma
is dependent on calcium-sensing receptor expression and function
Narasimharao Bhagavathula1, Andrew W. Hanosh1, Kamalakar C. Nerusu1, Henry Appelman1, Subhas Chakrabarty2
and James Varani1*
1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
2Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University Cancer Institute, Springfield, IL
An siRNA directed against the extracellular calcium-sensing re-
ceptor (CaSR) was used to down-regulate this protein in CBS co-
lon carcinoma cells. In additional studies, we utilized a variant of
the parental CBS line that demonstrates CaSR expression but
does not upregulate this protein in response to extracellular Ca21.
In neither the siRNA-transfected cells nor the Ca
21
-nonresponsive
variant cells did inclusion of Ca21 in the culture medium inhibit
proliferation or induce morphological alterations. Extracellular
Ca21 also failed to induce E-cadherin production or a shift in b-
catenin from the cytoplasm to the cell membrane. In mock-trans-
fected cells and in a Ca
21
-responsive variant line derived from the
same parental CBS cells, Ca21 treatment resulted in growth-
reduction. This was accompanied by increased E-cadherin pro-
duction and a shift in b-catenin distribution from the cytoplasm to
the cell membrane. Additionally, down-regulation of c-myc and
cyclin D1 expression was observed in mock-transfected cells and
in the Ca21-responsive variant line (along with reduced T cell fac-
tor transcriptional activation). Neither c-myc nor cyclin D1 was
significantly down-regulated in the siRNA-transfected cells or in
the Ca21-nonresponsive variant cells upon Ca21 stimulation. In
histological sections of human colon carcinoma CaSR was signifi-
cantly reduced as compared to the level in normal colonic crypt
epithelial cells. Where CaSR expression was high, strong surface
staining for E-cadherin and b-catenin was observed. Where CaSR
expression was reduced, b-catenin surface expression was likewise
reduced.
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Extracellular Ca21 is a growth-regulator and cancer chemopre-
ventative in the colon.1–6 In vitro studies have demonstrated that
maintenance of human colon carcinoma cells in Ca21-free me-
dium allows the cells to remain loosely attached to the substratum
and to one another and promotes proliferation. When extracellular
Ca21 (1.4 mM, final concentration) is included in the culture me-
dium, growth slows, the cells take on a flattened appearance and
behave as a cohesive epithelial unit.7 How extacellular Ca21 acts
to down-regulate proliferation and alter morphological and adhe-
sive features in colon carcinoma cells is not fully understood.
Recent studies provide evidence that the extracellular Ca21-sens-
ing receptor (CaSR) is required, based on the demonstration of
reduced expression of this protein in colon carcinoma tissue as
compared to normal colonic mucosa.8–10 In a recent study with a
colon carcinoma cell line (CBS), we isolated a subpopulation of
cells that expressed CaSR immunochemically, but unlike the pa-
rental cells, did not upregulate CaSR upon exposure to extracellu-
lar Ca21. In these cells, Ca21 failed to suppress growth.7 The
Ca21-treated cells also failed to express morphological changes
(increased flattening and increased cell–cell contact) associated
with Ca21 treatment in the parental cells.
The present study continues our efforts to elucidate the role of
CaSR expression and function in colon cancer cell biology. Here
we present evidence using an siRNA directed against the CaSR as
well as the variant cells with the Ca21-nonresponsive CaSR that
in the absence of a functional CaSR, extracellular Ca21 does not
upregulate E-cadherin or induce cell surface accumulation of E-
cadherin and b-catenin as it does in parental or mock-transfected
CBS cells. Cells lacking a functional CaSR continue to proliferate
and fail to flatten out or form cell–cell contacts as the parental
cells normally do in the presence of extracellular Ca21.
Materials and methods
Cell culture
The parental CBS colon carcinoma cell line and 2 subpopula-
tions referred to as Ca21-responsive (R1) and Ca21-nonresponsive
(NR1) variants were available from previous studies.7 The paren-
tal cells and the 2 variant lines were routinely maintained in Ca21-
free Spinner modified minimal essential medium (SMEM, Sigma
Aldrich, St. Louis, MO) supplemented with nonessential amino
acids and 5% dialyzed fetal bovine serum (FBS). Growth was at
37C in an atmosphere of 5% CO2 and 95% air. Cells were subcul-
tured by brief exposure to trypsin as required.
SiRNA treatment
A hairpin siRNA targeting the 30 end of the CaSR gene tran-
script was used to down-regulate CaSR (Dharmacon RNA Tech-
nologies, Lafayette, CO). Transfection of the parental CBS cells
with the siRNA was done using the GeneSilencer siRNA Trans-
fection Reagent (Genlantis, San Diego, CA) according to the man-
ufacturer’s instructions. Briefly, cells were plated in 6-well tissue
culture dishes at a density of 33 105 cells per well and transfected
with 1 lg of siRNA. Mock transfection using the same reagent
and a nonspecific control sequence was performed with each
experiment. After transfection, cells were incubated at 37C in an
atmosphere of 95% air and 5% CO2 in SMEM containing 5% FBS
and allowed to recover for 2 days before further use in experi-
ments. At this point, cells were plated on Lab Tek II chamber
slides and incubated for a further 3 days in SMEM 1 5% dialyzed
FBS with or without the addition of 1.4 mM Ca21 to the medium.
After this incubation, cells were examined by immunofluores-
cence for expression of b-catenin as described later. Lysates were
prepared from cells treated the same way and analyzed for CaSR
and E-cadherin by Western blot.
T cell factor transcriptional activity
Constitutive T cell factor transcriptional activation activity
(CTAA) was measured in R1 cells and in NR1 cells with a dual lu-
ciferase reporter assay (Promega, Madison, WI) as a ratio of lucif-
erase activity from the pTOPFLASH vector to the pFOPFLASH
vector.9 All luciferase activities were normalized for transfection
efficiency by cotransfection with pRL Renilla luciferase vector.
Briefly, cells in 6-well culture plates were transfected with pTop-
Flash/pRL Renilla or pFopFlash/pRL Renilla and allowed to
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recover for 24 hr. The medium was then replenished with either
standard culture medium with no exogenous Ca21 or with medium
supplemented with 1.4 mM Ca21. Luciferase assays were then
performed 24 hr later.
Immunofluorescence
Immunostaining was done as follows: Briefly, cells were grown
on uncoated Lab Tek II chamber slides in Ca21-free SMEM (5%
dialyzed FBS) or in the same medium supplemented with extracel-
lular Ca21 to a final concentration of 1.4 mM. After 3 days, cells
were fixed with 4% formaldehyde for 20 min. After fixation, cells
were washed twice with wash buffer (0.05% Tween-20 in Dulbec-
co’s Phosphate Buffered Saline [DPBS]), followed by permeabili-
zation with 0.1% Triton X-100 for 10 min. Cells were again
washed and then exposed to a blocking solution consisting of 1%
BSA in DPBS for 30 min. Next, cells were treated with a mono-
clonal antibody to b-catenin (Chemicon, Temicula, CA) or with
an antibody to E-cadherin (BD Biosciences; San Jose, CA) in
blocking solution for 1 hr. After 3 subsequent washing steps with
DPBS (5 min each), cells were treated with Alexa Fluor 488-con-
jugated secondary antibody in blocking solution and incubated for
45 min (Invitrogen, Carslbad, CA). After 3 additional washing
steps, the cells were rinsed one time with water. Coverslips were
mounted onto the microscope slides with Prolong Anti-fade
(Invitrogen). Stained cells were examined with a Zeiss LSM 510
confocal microscope using a 633 (C-Apochr) NA 5 1.2 water
immersion objective lens. Laser excitation wavelengths included
364, 488 and 543 nm scanned in sequence by the line method.
Western blots
Extracts were prepared from parental CBS cells, from R1 and
NR1 variants and from mock-transfected or siRNA-transfected
cells as follows: Cells were washed once in DPBS before addition
of lysis buffer (Cell Signaling Technologies, Danvers, MA). After
15 min of incubation in lysis buffer at 4C, cells were scraped into
the buffer and sonicated (5 pulses of 3 sec each) using a Fisher
550 Sonic Dismembrator (Pittsburgh, PA). The lysates were cen-
trifuged for 15 min at 14,000g and the supernatant fluids were col-
lected for Western blots. Western blotting was performed as
described previously7 using a rabbit polyclonal anti-b-catenin
antibody (Chemicon, Temecula, CA), a rabbit polyclonal antibody
raised against a synthetic peptide of the human CaSR molecule
(Affinity Bioreagents, Golden, CO) or a mouse monoclonal anti-
E-cadherin antibody (BD Biosciences, San Jose, CA). Anti-b-
tubulin (Santa Cruz Biotechnology, Santa Cruz, CA) served as
control.
Proliferation assay
Proliferation studies were carried out as follows. Cells were
plated in 24-well tissue culture dishes at a density of 4 3 104 cells
per well, using Ca21-free SMEM with 5% dialyzed FBS as culture
medium. Cells were allowed to attach overnight. The next day,
cells were washed and incubated under the desired conditions for
3 days. Proliferation was measured by detaching the cells with
trypsin and enumerating them with a particle counter (Coulter
Electronics, Hialeah, FL).
Cell fractionation
Cells were plated in 100-mm culture dishes at a density of 1.5
3 106 cells per dish, using Ca21-free SMEM with 5% dialyzed
FBS as culture medium. Cells were allowed to attach overnight.
The next day, cells were incubated in fresh SMEM with 5% dia-
lyzed FBS with or without 1.4 mM Ca21. After 3 days of incuba-
tion, cells were harvested and lysed. Membrane extraction was
FIGURE 2 – b-Catenin expression in R1 and NR1 variants of CBS
cells: Confocal fluorescence microscopy. R1 and NR1 cells were incu-
bated in either Ca21-free medium or medium containing 1.4 mM
Ca21 for 3 days and stained with b-catenin antibody. Confocal fluo-
rescence microscopy was used for detection. In the absence of extrac-
ellular Ca21, diffuse staining was observed in both populations. In
Ca21-containing medium, peripheral staining was observed in R1
cells but the staining pattern in NR1 cells was similar to what was
observed in the absence of Ca21. Results are representative of 3 inde-
pendent experiments with consistent results.
FIGURE 1 – E-cadherin expression in R1 and NR1 variants of CBS
cells: Confocal fluorescence microscopy. R1 and NR1 cells were
grown for 3 days under Ca21-free conditions or in the presence of 1.4
mM extracellular Ca21. At the end of the incubation period, immuno-
fluorescence staining for E-cadherin was done. Confocal fluorescence
microscopy was used for detection. In the absence of extracellular
Ca21, diffuse staining was observed in both populations. In Ca21-con-
taining medium, areas of intense focal staining was observed in R1
cells but the staining pattern in NR1 cells was similar to what was
observed in the absence of Ca21. Results are representative of 3 inde-
pendent experiments with consistent results.
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done using the Mem-PER Eukaryotic Membrane Protein Extrac-
tion Reagent Kit (Pierce Biotechnology, Rockford, IL) according
to the manufacturer’s phase-partitioning protocol for mammalian
cells. The membrane fraction and soluble fraction containing cyto-
plasm and nucleus were used for western blotting as described ear-
lier. Prior to loading the gels, protein levels in each preparation
were determined using the BCA protein determination kit (Pierce
Biotechnology) and equal amounts of protein were loaded onto
each lane. After electrophoresis and protein transfer to the nitro-
cellulose filters, we used Ponceau S reversible staining solution
(Pierce Biotechnology) to visualize the transferred proteins and to
confirm that comparable amounts of total protein were transferred.
To determine the degree to which membrane enrichment (or
depletion) was achieved, we compared expression of a cell surface
protein (epidermal growth factor receptor) and a cytosolic protein
(total ERK) by Western blotting of cytoplasmic and membrane
fractions. In every case, greater than 95% of the total ERK immu-
noreactivity was in the cytoplasmic fraction with barely detectable
reactivity in the membrane fraction. At the same time, most of the
EGFR (75–80%) was found in the membrane fraction with the re-
mainder in the cytoplasmic fraction.
Immunohistochemistry
Five-lm thick sections of formalin-fixed, paraffin-embedded
surgical specimens of 6 invasive colon tumors were obtained from
the surgical pathology service at the University of Michigan Hos-
pitals. The sections were stained by the immunoperoxidase
method using the same antibodies to CaSR, E-cadherin, b-catenin
indicated earlier. In each case, the reaction product was visualized
using diaminobenzadine as the chromogenic substrate. Immuno-
stained sections were examined by light microscopy. A hematoxy-
lin and eosin-stained section for each tissue was examined in
parallel.
Results
Effects of extracellular Ca21 on E-cadherin and b-catenin
distribution in Ca21-responsive and nonresponsive CBS cells:
Confocal immunofluorescence
Figure 1 demonstrates the effects of extracellular Ca21 on the
distribution of E-cadherin in R1 and NR1 variants of the CBS line.
The 2 isolates were incubated for 3 days in Ca21-free or Ca21-
containing medium and then examined by confocal fluorescence
FIGURE 4 – Effect of extracellular Ca21 on expression of CaSR, E-
cadherin and b-catenin in siRNA treated CBS cells. (a) siRNA-trans-
fected and mock-transfected cells were grown for 3 days under Ca21-
free conditions or in the presence of 1.4 mM extracellular Ca21. At
the end of the incubation period, lysates were prepared from the cells
and probed for CaSR and E-cadherin expression by Western blot anal-
ysis. Blots are representative of 3 independent experiments with con-
sistent results. (b) Immunofluorescence staining of siRNA-transfected
and mock-transfected cells for b-catenin. Cells were incubated in ei-
ther Ca21-free medium or medium containing 1.4 mM Ca21 for 3
days and stained with b-catenin antibody. Confocal fluorescence mi-
croscopy was used for detection. Results are representative of 3 inde-
pendent experiments with consistent results.
FIGURE 3 – E-Cadherin and b-catenin distribution in R1 and NR1
variants of CBS cells: Western blot analysis of cytoplasmic and mem-
brane fractions. (a) R1 and NR1 cells were grown in Ca21-free me-
dium or medium containing 1.4 mM Ca21 for 3 days. Fractions were
prepared using a phase-separation technique and E-cadherin and b-
catenin were assessed by western blotting. The blots are representative
of 3 independent experiments with consistent results. Controls for
these studies include EGF receptor as a membrane marker and total
ERK protein as a cytosolic marker. (b) The complete SDS-PAGE pro-
files of the extracts used are shown. Lanes 1–8 correspond to the 8
lanes (n order) presented in panel (a) above. [Color figure can be
viewed in the online issue, which is available at www.interscience.
wiley.com.]
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microscopy as described in the Materials and Methods Section.
Under Ca21-free conditions, E-cadherin exhibited a diffuse stain-
ing pattern in both populations. In Ca21-supplemented medium,
areas of concentrated focal fluorescence were observed in the R1
population. However, in the NR1 population, the fluorescence pat-
tern remained diffuse (Fig. 1).
In parallel, b-catenin expression and distribution was assessed.
In Ca21-free medium, b-catenin was detected throughout the cell
in both R1 and NR1 cells. In the presence of extracellular Ca21,
b-catenin was redistributed to the periphery of the cell in the R1
population. While it was impossible to prove that all of the b-cate-
nin was localized to the cell surface, fluorescence in the perinu-
clear area of the cell was clearly reduced as compared to cells
maintained in the absence of Ca21 (Fig. 2). In contrast, NR1 cells
showed no difference in the b-catenin immunofluorescence pat-
tern between Ca21-free and Ca21-containing conditions (Fig. 2).
Effects of extracellular Ca21 on E-cadherin and b-catenin
distribution in Ca21-responsive and nonresponsive CBS cells:
Cell fractionation
R1 and NR1 cells were grown in Ca21-free and Ca21-contain-
ing medium as earlier. At the end of the incubation period, mem-
brane and cytoplasmic fractions were prepared from cell lysates
and examined for E-cadherin expression (Fig. 3). Under Ca21-free
conditions, E-cadherin expression in both variants was similar
(i.e., mostly in the cytoplasmic fraction). In the presence of extrac-
ellular Ca21, the distribution of E-cadherin was shifted from the
cytoplasmic to the membrane fraction in R1 cells. In contrast,
there was essentially no change in distribution pattern in NR1 cells
under the same conditions (Fig. 3).
The same membrane and cytoplasmic fractions were examined
by western blotting for b-catenin expression. Under Ca21-free
conditions, the majority of the b-catenin in both variants was in
the cytoplasmic fraction. In the presence of extracellular Ca21, the
distribution of b-catenin was shifted from the cytoplasmic to the
membrane fraction in R1 cells. In contrast, there was essentially
no change in distribution pattern in NR1 cells under the same con-
ditions (Fig. 3).
Effects of extracellular Ca21 on E-cadherin and b-catenin
expression and distribution in siRNA-transfected and
mock-transfected CBS cells
The earlier experiments suggest that a functional CaSR is nec-
essary for extracellular Ca21 to modulate E-cadherin and b-cate-
nin distribution in CBS cells. To provide direct evidence for the
CaSR role, a vector-based siRNA technique was used to down-
regulate CaSR in parental CBS cells. In the initial experiments,
we compared CaSR expression in cells maintained in Ca21-free
medium with cells maintained in the presence of 1.4 mM Ca21.
As seen in Figure 4a, mock-transfected CBS cells expressed de-
tectable CaSR, and this protein was upregulated in medium con-
taining Ca21. In contrast, the level of the protein was reduced in
siRNA-transfected cells to virtually undetectable levels under
Ca21-free conditions and not upregulated by Ca21.
E-cadherin expression was examined next. Previous studies
have demonstrated Ca21-mediated upregulation of E-cadherin in
parental CBS cells (as well as in several other colon carcinoma
cell lines.9 As seen in Figure 4a, E-cadherin was upregulated in
mock-transfected cells in the presence of extracellular Ca21. In
contrast, there was little E-cadherin expression under the low-
Ca21 conditions in siRNA-transfected cells and no upregulation
with Ca21.
Next, we assessed intracellular distribution of b-catenin in
mock-transfected and siRNA-transfected cells by confocal immu-
nofluorescence. For these studies, CBS cells were transfected ei-
ther with the control vector or with the siRNA-containing vector
and incubated in Ca21-free medium or medium containing
1.4 mM Ca21 for 3 days. Figure 4b demonstrates b-catenin local-
ization in the absence or presence of extracellular Ca21. The
results were similar to those described earlier with the R1 and
NR1 populations. That is, in the mock-transfected cells, there was
a redistribution of b-catenin away from the nucleus and to the pe-
riphery of the cell under the influence of extracellular Ca21. In
FIGURE 5 – Effect of extracellular Ca21 on cell growth in the R1 and NR1 CBS cells and in mock-transfected and siRNA transfected CBS
cells. Proliferation of R1 and NR1 cells and proliferation of mock-transfected and siRNA-transfected cells under Ca21-free or Ca21-containing
conditions. Values shown are means and standard deviations based on triplicate samples in a single experiment. Statistical significance was
determined by ANOVA, followed by paired group comparisons. *Indicates differences from control group (no Ca21 supplementation) at the
p < 0.05 level. Proliferation assays were conducted 5 times with consistent results. Insert: Morphological appearance of R1 cells grown for
3 days in the absence or presence of Ca21-supplemented medium. [Color figure can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
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contrast, in siRNA treated cells, no peripheral localization of b-
catenin was observed under either condition.
Effects of extracellular Ca21 on CBS cell proliferation:
Requirement for functional CaSR
In a final series of experiments with CBS cells, we assessed the
effects of extracellular Ca21 on proliferation. Figure 5 (left panel)
demonstrates results with R1 and NR1 variants. Consistent with
our previous results,7 proliferation of the responsive cells (R1)
was reduced by about 40% in Ca21-containing medium as com-
pared to results obtained under Ca21-free conditions. In contrast,
there was no change in proliferation in the nonresponsive (NR1)
cells in Ca21-supplemented medium as compared to unsupple-
mented control medium. Proliferation of siRNA treated cells com-
pared to the mock-transfected cells was also assessed. As shown
in Figure 5 (right panel), statistically significant growth inhibition
was observed in Ca21-treated mock-transfected cells as compared
to the same cells cultured in Ca21-free medium. The degree of
growth inhibition was similar to that reported earlier with the pa-
rental CBS cells9 or with the R1 variant cells shown here. In con-
trast, there was no Ca21-mediated reduction in cell growth in
siRNA-treated cells as compared to the same cells in Ca21-free
medium.
In both the R1 variant cells and the mock-transfected cells,
Ca21-mediated growth inhibition was accompanied by a change
in morphology of the treated cells. That is, while the cells main-
tained a spherical appearance and were loosely attached to one
another and to the substratum under Ca21-free conditions, both
populations were more well-spread and more firmly attached to
one another and to the substratum in the presence of 1.4 mM
Ca21. In contrast, neither NR1 cells or mock-transfected cells
demonstrated a change in morphology in response to extracellular
Ca21. The insert in Figure 5 demonstrates the morphological dif-
ferences in the Ca21-responsive CBS variant under Ca21-free
(left) and Ca21-containing (right) conditions.
In parallel studies, we compared CTAA and expression of 2
growth-related proteins—i.e., c-myc and cyclin D1-in R1 versus
NR1 cells. For CTAA, cells in 6-well culture plates were trans-
fected with pTopFlash/pRL Renilla or pFopFlash/pRL Renilla and
allowed to recover for 24 hr. The medium was then replenished
with either standard culture medium with no exogenous Ca21 or
with medium supplemented with 1.4 mM Ca21. Luciferase assays
were then performed 24 hr later as described in the Materials and
Methods. Western blotting was used to assess c-myc and cyclin
D1 expression. As seen in Figure 6a, the ability of extracellular
Ca21 to suppress CTAA was reduced in the NR1 cells (23% reduc-
tion) as compared to R1 cells (78% reduction). Concomitantly,
Ca21-mediated reduction in the levels of c-myc and cyclin-D1 was
also much lower in the NR1 cells than in R1 cells. As shown in
Figure 6b, expression of both proteins was significantly reduced in
the mock-transfected cells in the presence of Ca21 as compared to
Ca21-free conditions. In siRNA-transfected cells, however, the
reduction in response to extracellular Ca21 was much less.
Immunohistochemical localization of CaSR, b-catenin
and E-cadherin in colon carcinoma
Histological sections from 6 cases of invasive colon cancer
were examined by light microscopy after staining with antibodies
to CaSR, E-cadherin and b-catenin. In each section there were
areas of normal colonic mucosa and areas of malignant tumor. To
summarize, CaSR was strongly expressed in morphologically nor-
mal colonic crypt epithelium, particularly in the cells in the upper
half of the crypt and at the surface. CaSR staining was signifi-
cantly reduced in areas of malignant tumor. There was also vari-
ability within the tumors. In some areas of tumor, there was no de-
tectable CaSR, whereas in other areas, staining was present,
though weaker than seen in normal structures. Where staining was
detected in malignant tissue, it was observed in areas of the tumor
with evidence of lumen formation. Figure 7 shows an area of colo-
nic mucosa, in which both normal and malignant epithelium are
present. As seen in Figure 7b, CaSR reactivity can be seen in nor-
mal mucosa but is essentially missing from the tumor. These find-
ings are consistent with past reports.8–10
Sections from the same 6 specimens were also stained for b-cat-
enin. In all 6 cases, there was diffuse cytoplasmic staining and a
more intense staining of the border between adjacent cells in the
areas of normal mucosa. Nuclear b-catenin staining was routinely
not observed in the normal crypts. In areas of malignant tumor,
the b-catenin staining pattern was (in contrast to the consistent
results obtained in normal colonic crypts) highly variable. In some
areas, the malignant epithelial cells showed the same diffuse cyto-
plasmic and strong cell surface staining as did epithelial cells in
normal crypts. However, even in these areas, strong nuclear stain-
ing was also observed in some of the cells. In other areas, strong
cytoplasmic and nuclear staining (without evidence of junctional
staining) throughout the entire section was observed. Figure 7c
shows b-catenin staining patterns in normal and malignant epithe-
lial cells from the same area shown in Figures 7a and 7b.
The E-cadherin staining pattern was significantly different from
that seen with either CaSR or b-catenin. Specifically, E-cadherin
was detected in virtually all of the cells in both normal and malig-
nant areas in all of the histological sections. Where glandular
structures were observed (i.e., in either normal or malignant;
whether or not CaSR was also detected), prominent staining along
cell–cell junctures was observed (Fig. 7d). It was only in the most
FIGURE 6 – Effect of extracellular Ca21 on cell growth, CTAA and
expression of c-myc and cyclin D1 in the R1 and NR1 CBS cells and
in mock-transfected and siRNA transfected CBS cells. (a) CTAA was
measured using the dual luciferase reporter assay. Results were
expressed as percent inhibition of CTAA in the presence of extra-
cellular Ca21 relative to control cells cultured in the absence of Ca21.
Values obtained represent the ratio of luciferase activity from the
pTOPFLASH vector to the pFOPFLASH vector and normalized to
transfection efficiency by cotransfection with the pRL Renilla lucifer-
ase vector. Error bars represent the standard error of the mean of tripli-
cate determinations. Statistical significance was determined using the
Student t-test. *Indicates difference from control group (no Ca21 sup-
plementation) at the p < 0.05 level. (b) Cells from each of the 4 popu-
lations were grown under Ca21-free or Ca21-containing conditions for
3 days. Lysates were prepared from these cells and probed for c-myc
and cyclin D1 expression by Western blot analysis. Blots are represen-
tative of 2 independent experiments with consistent results. [Color
figure can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
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advanced areas of the tumor, where glandular structures were not
evident, that diffuse staining throughout the cell rather than stain-
ing of cell–cell junctures was seen (Fig. 7d, insert).
Discussion
CaSR is a G-protein-coupled. CaSR was initially identified in
the parathyroid gland, where it senses minute changes in extracel-
lular Ca21 concentration.11,12 Subsequently, this protein was dem-
onstrated in a number of different types of epithelial cells
(including those of the gastrointestinal tract).13,14 A variety of
indirect evidence suggests that CaSR plays a role in mediating the
effects of extracellular Ca21 on epithelial cell function.7–9,14,15
Definitive evidence that CaSR is required for Ca21-mediated
events is lacking, however. Furthermore, how CaSR regulates
Ca21 responses in epithelial cell is not fully understood. Here we
have used an siRNA approach to down-regulate CaSR expression
in a line of human colon carcinoma cells. In the CaSR-down-regu-
lated cells, the addition of extracellular Ca21 to the culture me-
dium failed to suppress growth or induce cell flattening and cell–
cell contact as it did in mock-transfected cells. In parallel studies,
we used a variant of the CBS line that expresses detectable CaSR
(immunochemically) but does not upregulate receptor expression
in response to extracellular Ca21.7 The Ca21-nonresponsive vari-
ant, like the siRNA-treated cells, did not undergo growth suppres-
sion or exhibit the other morphological changes seen in Ca21-re-
sponsive cells exposed to extracellular Ca21.
What are the critical down-stream events in the Ca21 signaling
pathway that depend on CaSR? Our data suggest that CaSR
expression and function are necessary for Ca21 to upregulate E-
cadherin synthesis and to organize E-cadherin and b-catenin at the
cell surface. When Ca21-responsive CBS (R1) cells were main-
tained in culture under Ca21-free conditions, both E-cadherin and
b-catenin were diffusely expressed throughout the cell as detected
by confocal fluorescence microscopy. When cell-fractionation was
done, the majority of both proteins segregated into the cytoplasmic
rather than membrane pool. However, in the presence of 1.4 mM
extracellular Ca21, there was a redistribution of both proteins to
the cell surface. In contrast, with both the nonresponsive variant
cells and the siRNA-treated cells, exposure to extracellular Ca21
failed to prevent a redistribution of E-cadherin and b-catenin from
the cytoplasmic to membrane pool. The inability of the cells to
properly organize these proteins at the cell surface could have
important implications for epithelial cell function. It is well-estab-
lished that E-cadherin is a critical component of cell surface adhe-
sion complexes that form in differentiated epithelia and that b-cat-
enin accumulates at the cell surface along with E-cadherin.16–21 In
the absence of b-catenin, E-cadherin is able to mediate a weak
cell–cell adhesive interaction.22 Strong cell–cell adhesion and dif-
ferentiation, however, do not occur. This requires stabilization of
FIGURE 7 – CaSR, b-catenin and E-cadherin immunoreactivity in normal and malignant human colon tissue. Formalin-fixed specimens of
recently diagnosed cases of colon carcinoma (n 5 6) were stained with antibodies to CaSR, b-catenin and E-cadherin using the immunoperoxi-
dase method. (a) Hematoxylin and eosin-stained sections through an area demonstrating normal (right side) and malignant (left side) epithelium.
(b) CaSR: Strong immunostaining for CaSR was observed in normal colonic crypt epithelium. Tumor epithelial cells were virtually negative. (c)
b-catenin: In normal crypt epithelium, staining was observed at the border between cells. In the tumor, strong cytoplasmic and nuclear staining
was evident. The distinct border staining was lost. (d) E-cadherin: Junctional staining and intracellular staining were observed in both normal
and malignant areas of the section. Insert: Where individual tumor cells were seen, border staining was lost and diffuse staining throughout the
cell was evident. The findings presented here were typical of what was seen in all of the cases examined (All sections magnified X66; Insert
X220).
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the cell surface adhesion complex through interaction with the cy-
toskeleton; b-catenin is one of the critical components mediating
this interaction.23–28 Under conditions where both E-cadherin and
b-catenin are localized at the cell surface and functional, epithelial
cells behave as a cohesive unit. In contrast, when these proteins
are not functional, discohesion is prominent. The epithelial cells
behave as single cells. Under such conditions, cell motility and
invasion of single cells and small groups of cells into the sur-
rounding stroma can be seen.18,20,24,25,27,28
In addition to interfering with invasion-related properties, local-
ization of E-cadherin and b-catenin at the cell surface could also
act to suppress malignant outgrowth by influencing proliferation
and the multiple signaling pathways that influence proliferation.
Past studies have demonstrated a role for cytoplasmic/nuclear b-
catenin in upregulation of NFjB, presumably through signaling
events involving the p38 mitogen-activated protein (MAP) kinase
pathway.29 Other studies have shown a connection between E-cad-
herin and MAP kinase signaling.30 Using an immortalized epithe-
lial cell (HaCat), it was shown that when Ca21-dependent cell–
cell contacts were formed, ligand-independent activation of the
epidermal growth factor receptor occurred, leading to ERK phor-
phorylation. A role for E-cadherin-mediated cell–cell adhesion
was implied, based on the finding that disruption of E-cadherin-
mediated contacts between cells interfered with ERK activation.
Another important role for cytoplasmic/nuclear b-catenin
involves activation of Wnt signaling. Past studies have shown that
when b-catenin is translocated into the nucleus, it functions as a
transcription factor activator for growth-promoting molecules in
the Wnt signaling pathway.31–33 Consistent with this, the data pro-
vided here demonstrate a relationship between CaSR expression
and function, cell surface b-catenin localization, reduced CTAA
and reduced expression of c-myc and cyclin D1 in CBS cells.
Both c-myc and cyclin-D1 are down-stream targets in the Wnt sig-
naling pathway.34,35
Although the findings presented here were obtained with a line
of human colon carcinoma cells, the findings are likely to have
implications for human colon cancer. We8,9 and others10 have
shown in the past that expression of CaSR is reduced or lacking
entirely in histological sections of colon carcinoma. Those cancers
with the most anaplastic features exhibited the least CaSR.8,9 In
the small series of colon carcinomas studied here, we observed a
relationship between CaSR expression and b-catenin staining at
the cell surface. Where CaSR expression was detected (i.e., in nor-
mal colonic mucosa and some areas of histologically differenti-
ated tumor), b-catenin reactivity was seen primarily along the
border between adjacent cells. Where CaSR expression was
absent, b-catenin was primarily intracytoplasmic or intranuclear
rather than cell surface. Thus, to the exent that cytoplasmic or nu-
clear b-catenin is associated with continued proliferation, the
same mechanisms that limit proliferation of CBS cells in vitro
may be operative in vivo, as well.
Of interest, there did not seem to be a similar relationship
between CaSR and E-cadherin expression. E-cadherin immuno-
reactivity was observed between adjacent cells in areas of tumor
that were negative for CaSR expression (as well as in areas where
CaSR was expressed). Only at the invasive front, where all evi-
dence of glandular structure was lost did we see a lack of surface
E-cadherin expression. Perhaps in the CaSR-negative areas, the
detectable E-cadherin is analogous to the E-cadherin that is
loosely bound (and not fully functional) on epithelial cells in vitro
in the absence of extracellular Ca21.22 Immunochemical
approaches are inadequate, of course, to assess functionality.
In summary, an intact Ca21 signaling system is important for E-
cadherin upregulation and for sequestration of E-cadherin and b-
catenin at the cell surface in CBS colon carcinoma cells. When the
signaling system is intact, the cells assume a flattened appearance
and grow as a cohesive epithelial unit. Proliferation is reduced.
When the signaling system is not intact, the cells do not behave as
a cohesive unit. Cells remain loosely attached to one another, do
not exhibit a flattened appearance and continue to proliferate. The
present studies show that expression and function of the CaSR is a
critical component of this signaling system in colon carcinoma
cells. Observations in colon carcinoma tissue sections are consist-
ent with the in vitro findings. The issue that needs to be addressed
in vivo is whether the lack of CaSR expression in colon carcinoma
reflects defects in CaSR or whether the lack of CaSR expression
is, itself, the result of some other more fundamental defect. Fur-
ther work is necessary to address this issue.
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